Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MLEC vs MRNO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MLEC Captures Overall Composite Edge (40.8 SELL vs 46.8 HOLD), While MRNO Leads 3–2 on Growth & Valuation Pillars

MLEC Overall Winner 6-Pillar Tally: MLEC 2 – 3 MRNO (1 Tie) Matrix Metrics: MLEC 4 – 4 MRNO

As of Nov 16, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over Murano Global Investments PLC (MRNO) on higher Unified Composite conviction (40.8/100 SELL vs. 46.8/100 HOLD) after splitting the core matrix 4–4 (led by Valuation Multiples, Profitability & Quality), while MRNO wins 3–2 across the 6-pillar growth and valuation breakdown. MLEC trades at $0.85 (N/M Forward P/E, 0.0% operating margin) versus MRNO at $0.17 (N/M Forward P/E, -29.2% operating margin).

  • Composite vs. Pillar Nuance: While MRNO currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. MLEC 40.8/100 SELL), MLEC captures the overall institutional head-to-head verdict (4–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -29.2% operating margin) and revenue trajectory (+948.3% vs. -14.9% YoY).
  • Technical & Structure Timing Caution: MLEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile MRNO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MLEC vs MRNO
MLEC NASDAQ Head-to-Head Winner
Moolec Science SA Ordinary Shares
Textile Mill Products
$0.85
-39.29% 1D
Market Cap $1.0M
TTM Revenue $7.8M
Forward P/E N/M
Beta / 30D Vol 0.05β · 208% Vol
Unified Composite Score
40.8 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -30.9%), weak momentum, RSI 17
RSI-14: 16.8 · SMA20: $2.06 · SMA50: $4.58
MRNO NASDAQ
Murano Global Investments PLC Ordinary Shares
Hotels & Motels
$0.17
-7.4% 1D
Market Cap $15.8M
TTM Revenue $1.14B
Forward P/E N/M
Beta / 30D Vol 0.49β · 76% Vol
Unified Composite Score
46.8 / 100 HOLD
Tech 40.0 Fund 53.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.5%), weak momentum, RSI 36
RSI-14: 35.9 · SMA20: $0.21 · SMA50: $0.24

6-Pillar Scorecard Institutional Category Breakdown (MLEC 2 – 3 MRNO)

Columns: Metric · MLEC · MRNO
1. Valuation Multiples MLEC
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.1x N/M
2. Growth & Scale MRNO
Revenue Growth (YoY) +948.3% -14.9%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $7.8M $1.14B
Market Cap $1.0M $15.8M
3. Profitability & Quality MLEC
Gross Margin -8.2% 39.9%
Operating Margin 0.0% -29.2%
Net Profit Margin 0.0% -24.8%
Return on Equity (ROE) -174.7% -7.5%
4. Balance Sheet & Cash Flow MRNO
Cash Generation (TTM) -$8.1M EBITDA -$95M EBITDA
Cash Flow Margin -103.1% EBITDA Mgn -8.4% EBITDA Mgn
Net Cash / Leverage $0.70 Book/Sh · -174.7% ROE $1.55 Book/Sh · -7.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat MRNO
OpEx & R&D Intensity N/A 69.1% of Rev ($788M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Real Estate - Development Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MLEC (4) vs MRNO (4)
Institutional Metric MLEC MRNO Criterion Row Edge
Market Capitalization
Scale
$1.0M $15.8M Larger Scale MRNO
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+948.3% -14.9% Higher Growth MLEC
Operating Margin (TTM)
Profitability
0.0% -29.2% Higher Margin MLEC
Net Profit Margin
Profitability
0.0% -24.8% Higher Margin MLEC
Return on Equity (ROE)
Capital Efficiency
-174.7% -7.5% Higher ROE MRNO
52-Week Range Position
Momentum
3% ($0–$23) 0% ($0–$3) Stronger Trend MLEC
Beta / 30D Volatility
Risk Regime
0.05β · 208% Vol 0.49β · 76% Vol Lower Realized Risk MRNO
Unified Institutional Score
Composite Signal
40.8 / 100 (SELL) 46.8 / 100 (HOLD) Higher Composite MRNO
Trailing 12M Revenue (USD)
Operating Scale
$7.8M $1.14B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-8.2% 39.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$8.1M EBITDA ($0.70 Book/Sh · -174.7% ROE) -$95M EBITDA ($1.55 Book/Sh · -7.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MRNO +60.89 pp
MLEC: -82.11% · MRNO: -21.22%
3M Horizon MRNO +83.37 pp
MLEC: -87.8% · MRNO: -4.43%
6M Horizon MRNO +70.61 pp
MLEC: -91.8% · MRNO: -21.19%
1Y Horizon MLEC +133.11 pp
MLEC: +41.67% · MRNO: -91.44%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period MLEC Revenue MRNO Revenue MLEC Op. Margin MRNO Op. Margin Margin Leader
Q4 '24 $10M N/A -77.9% N/A MLEC
Q1 '25 N/A $1.28B N/A -20.0% MRNO
Q4 '25 N/A $1.37B N/A -12.1% MRNO

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MLEC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MLEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MRNO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MRNO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MLEC Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
MRNO Moat Profile Cyclical / Execution-Driven Positioning
Real Estate - Development Operator
Competes within the Real Estate - Development value chain with $15.8M market capitalization and -29.2% operating margin.
OpEx & R&D Reinvestment 69.1% of Rev ($788M)
90D Engineering Disclosures 0 Published

Investor FAQ MLEC vs MRNO Key Questions & Quantitative Answers

As of Nov 16, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over Murano Global Investments PLC (MRNO) on higher Unified Composite conviction (40.8/100 SELL vs. 46.8/100 HOLD) after splitting the core matrix 4–4 (led by Valuation Multiples, Profitability & Quality), while MRNO wins 3–2 across the 6-pillar growth and valuation breakdown. MLEC trades at $0.85 (N/M Forward P/E, 0.0% operating margin) versus MRNO at $0.17 (N/M Forward P/E, -29.2% operating margin). Composite vs. Pillar Nuance: While MRNO currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. MLEC 40.8/100 SELL), MLEC captures the overall institutional head-to-head verdict (4–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -29.2% operating margin) and revenue trajectory (+948.3% vs. -14.9% YoY). Technical & Structure Timing Caution: MLEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile MRNO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MRNO leads the Growth & Scale pillar: MLEC posts +948.3% YoY revenue growth and +0.0% YoY earnings growth on $7.8M TTM revenue (-8.2% gross margin, 0.0% operating margin), compared with MRNO at -14.9% YoY revenue growth and +0.0% YoY earnings growth on $1.14B TTM revenue (39.9% gross margin, -29.2% operating margin). Across the 3-period historical trajectory (Q4 '24 to Q4 '25), MLEC cumulative revenue shifted N/A while MRNO shifted +7.0%. In operating R&D and SG&A reinvestment, MLEC deploys N/A (0 90-day corporate R&D disclosures) versus 69.1% of Rev ($788M) (0 disclosures) for MRNO.

MLEC screens cheaper on headline valuation multiples. MLEC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-103.1% EBITDA margin), whereas MRNO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-8.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MLEC (-174.7% ROE) versus MRNO (-7.5% ROE) capital efficiency.

In options market volatility and institutional positioning, MLEC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.05β · 208% Vol realized risk). By comparison, MRNO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 76% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.